Tag: International Progressive MS Alliance
Peer Baneke: celebración del compromiso de una líder inspiradora en Esclerosis Múltiple
After 18 years of dedicated service Peer Baneke, the Chief Executive of MSIF, will be retiring this December.
Global webcast: what we are learning from clinical trials
How all trials, successful or not, inform future research
Global webcast on mobility challenges in progressive MS
Research to monitor and maximise mobility
Transmisiones mundiales acerca de la esclerosis múltiple progresiva
Advances in treatment and research.
Global webcast on new treatments for progressive MS
Recent advances and promising researches
Transmisión mundial acerca de la desafíos cognitivos para personas con esclerosis múltiple progresiva
Catch up on advances in treatment and research.
Transmisión por Internet mundial sobre el fin de la progresión de la esclerosis múltiple
Research advances that could lead to breakthrough treatments in progressive MS
Why is it important for people affected by MS to be actively involved in research?
New survey launched by the International Progressive MS Alliance
3 millones de euros para avanzar en la investigación con miras a detener la progresión de la esclerosis múltiple
International Progressive MS Alliance invests €3 million in drug discovery project to develop therapies to stop MS progression.
Transmisión mundial sobre el dolor en la esclerosis múltiple progresiva
Answering questions and exploring advances in research
Cómo resolver el misterio de la progresión: la clave de los nuevos tratamientos para la esclerosis múltiple progresiva
Catch up with the latest webcast on unraveling the mystery of progression and identifying new targets for treatments
Transmisión global sobre el final de la esclerosis múltiple progresiva
Learn about important, new research initiatives that will fuel the development of breakthrough treatments for progressive MS.
¿Puede un análisis de sangre que mida los niveles de cadena liviana de neurofilamentos predecir la actividad de esclerosis múltiple en el futuro?
A study funded by the International Progressive MS Alliance shows a blood test may have potential in helping to predict future MS activity and response to therapy.
Respuesta a preguntas sobre la fatiga en esclerosis múltiple progresiva
Catch up on the latest webcast on fatigue treatment and research from the International Progressive MS Alliance
Mapeo de la agenda de investigación mundial para eliminar la esclerosis múltiple progresiva
Leaders of the International Progressive MS Alliance have published a paper proposing a global research strategy to prioritise and coordinate the efforts needed to find more and better treatments, and improve quality of life of people living with progressive MS.
Ganador del premio Young Investigator Award 2021
Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS
Progressive MS Alliance – MS stories from across the world
Find out about the lives of seven people affected by progressive MS.
La FDA respalda la investigación adicional sobre la “cadena liviana de neurofilamentos”
The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the biomarker ‘neurofilament light chain’
El profesor Alan Thompson gana el prestigioso premio Charcot de EM
Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of MS
La Alianza financia 19 becas al desafío de la investigación en la búsqueda de respuestas para la progresión
In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in progressive MS
Respuesta a las preguntas sobre el tratamiento y la investigación de la EM progresiva: ¡Ver en español!
Watch the International Progressive MS Alliance webcast
Recibe información sobre los últimos avances en los tratamientos para EM progresiva
A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective treatments for progressive MS.
EM progresiva y novedosos tratamientos en rápido desarrollo
Global webcast on 4 March
Investigación sobre cómo combatir la inflamación del cerebro en la esclerosis múltiple gracias a la información del intestino
This paper was first published in Nature January 2021
Join the discussion on symptom management & well-being in progressive MS
Register for the Progressive MS Alliance's Facebook Live event
Un biomarcador potencial para la EM progresiva
The use of neurofilament light chain (NfL) as a biomarker could revolutionise clinical trials in progressive MS.
¿Cómo agilizamos la aplicación de tratamientos decisivos para la vida de personas con EM progresiva?
Join the discussion about research breakthroughs that could accelerate new treatments for people with progressive MS
Mitocondrias con gran energía: una posible vía para tratar la EM progresiva
New research funded by the International Progressive MS Alliance looks at ways that nerve fibres protect themselves from damage.
Answering today’s big questions in progressive MS
Watch the International Progressive MS Alliance webcast here
Discovering life-changing treatments for progressive MS
An International Progressive MS Alliance global webcast
Let’s talk about symptoms and well-being in progressive MS
Register for the Progressive MS Alliance's Facebook Live event on symptom management and well-being in progressive MS
Challenges in Progressive MS Awards: taking risks to reap rewards
Progressive MS Awards
La primera organización de EM en América Latina se une a la Alianza Internacional de la EM Progresiva
The International Progressive MS Alliance is growing!
Global webcast on solving progressive MS: progress achieved and hope for the future
Results released from first multi-drug clinical trial in MS
The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have ruled out three repurposed drugs for the treatment of progressive MS.
Blocking blood protein could protect nerves in MS
A treatment that blocks a type of protein that accumulates in the brain was able to reduce inflammation and damage to nerves in laboratory models of MS.
Conferencia de la Alianza de la EM Progresiva: rehabilitación y control de los síntomas
Researchers, clinicians and people living with MS, from around the world converged on the city of Toronto in Canada for the 3rd Congress of the International Progressive MS Alliance.
Miembros de la Federación Internacional de la EM se reúnen en Londres para celebrar el 50 aniversario del movimiento global de la MSIF.
More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in London in September for the MSIF Movement’s 50th Anniversary meetings.
La Alianza celebra una reunión fundamental en Londres
A meeting of minds took place at the recent International Progressive MS Alliance event in London
El director ejecutivo de MS Research Australia celebra el importante papel de las nuevas tecnologías para transformar la vida de las personas que tienen esclerosis múltiple
Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more